Skip to NavigationSkip to content


Monday, June 3, 2019 - Tuesday, June 4, 2019
Westminster University
London, United Kingdom

Event Type: Conference


Orphan Drugs and Rare Diseases Conference will bring together regulatory agencies, pharmaceutical companies, non-profit organisations and orphan drugs developers to construct an agenda that addresses the driving clinical and economic factors, policies and issues that will affect the development of orphan drugs globally including commercialisation, policies, reimbursement, and pricing.
• Rare Diseases Challenges and Opportunities • Challenges and Benefits in Investing in Rare Diseases • Critical analysis of Strategic Partnerships to Ensure successful Partnership  • Pricing strategy • Market access strategy • Patient involvement in clinical drug development • Clinical Trials: From Early Drug Development to Patient Recruitment • Key Economic Drivers in the Orphan Market: What is Driving the Industry and the Role of Governments? Europe’s Regulatory Landscape and future • Cell and Gene Therapy for Orphan Drugs: Challenges and Opportunities


Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches